23rd March 2015 Content supplied by: BD Diagnostic Systems
BD MAX™ STD Assays Receive CE Mark
The BD MAX™ CT/GC/TV and CT/GC assays, which are new additions to the BD Reproductive and Sexually Transmitted Infections Portfolio have received CE marking. The BD MAX™ CT/GC/TV and CT/GC assays can detect Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC) and Trichomonas vaginalis (TV) from a single specimen in just one run.
Collection options are flexible, allowing for male or female urines, self-collected vaginal swabs and clinician collected endocervical swabs. Once samples are loaded onto the BD MAX™ System, results will be ready in less than three hours, and all reagents are ready-to-use, room temperature storage.
The BD MAX™ System offers an efficient path to improved clinical outcomes by combining and automating real-time PCR extraction, amplification and detection and into a single platform capable of running both FDA-cleared and open-system assays. Such flexibility and standardization allow you to address a wide breadth of testing needs. The BD MAX™ System is part of a BD Life Sciences – Diagnostic Systems portfolio of molecular solutions.
For more information on BD Molecular Diagnostics, please visit: moleculardiagnostics.bd.com
Date Published: 23rd March 2015
Source article link: BD Diagnostic Systems
Hospital Starts Using BD Kiestra™
Smaller, Lighter Plastic Bottle Option